Thomson Medical Group Limited (FRA:3H5)

Thomson Medical Group Statistics

Total Valuation

FRA:3H5 has a market cap or net worth of EUR 1.02 billion. The enterprise value is 1.74 billion.

Market Cap	1.02B
Enterprise Value	1.74B

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	26.44B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	90.03%
Owned by Institutions (%)	0.45%
Float	2.52B

Valuation Ratios

PE Ratio	n/a
Forward PE	294.92
PS Ratio	3.34
PB Ratio	2.78
P/TBV Ratio	n/a
P/FCF Ratio	40.22
P/OCF Ratio	25.19
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.11, with an EV/FCF ratio of 68.67.

EV / Earnings	-54.65
EV / Sales	5.75
EV / EBITDA	52.11
EV / EBIT	169.79
EV / FCF	68.67

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 2.05.

Current Ratio	1.19
Quick Ratio	0.63
Debt / Equity	2.05
Debt / EBITDA	22.10
Debt / FCF	29.62
Interest Coverage	0.27

Financial Efficiency

Return on equity (ROE) is -8.35% and return on invested capital (ROIC) is 0.59%.

Return on Equity (ROE)	-8.35%
Return on Assets (ROA)	0.55%
Return on Invested Capital (ROIC)	0.59%
Return on Capital Employed (ROCE)	1.05%
Revenue Per Employee	142,945
Profits Per Employee	-14,929
Employee Count	2,185
Asset Turnover	0.25
Inventory Turnover	1.92

Taxes

In the past 12 months, FRA:3H5 has paid 4.25 million in taxes.

Income Tax	4.25M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+14.29%
50-Day Moving Average	0.04
200-Day Moving Average	0.03
Relative Strength Index (RSI)	47.16
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:3H5 had revenue of EUR 304.61 million and -31.81 million in losses. Loss per share was -0.00.

Revenue	304.61M
Gross Profit	147.59M
Operating Income	10.64M
Pretax Income	-27.16M
Net Income	-31.81M
EBITDA	27.90M
EBIT	10.64M
Loss Per Share	-0.00

Balance Sheet

The company has 76.25 million in cash and 750.00 million in debt, giving a net cash position of -673.76 million.

Cash & Cash Equivalents	76.25M
Total Debt	750.00M
Net Cash	-673.76M
Net Cash Per Share	n/a
Equity (Book Value)	366.74M
Book Value Per Share	0.01
Working Capital	33.96M

Cash Flow

In the last 12 months, operating cash flow was 40.42 million and capital expenditures -15.10 million, giving a free cash flow of 25.32 million.

Operating Cash Flow	40.42M
Capital Expenditures	-15.10M
Free Cash Flow	25.32M
FCF Per Share	n/a

Margins

Gross margin is 48.45%, with operating and profit margins of 3.49% and -10.44%.

Gross Margin	48.45%
Operating Margin	3.49%
Pretax Margin	-8.92%
Profit Margin	-10.44%
EBITDA Margin	9.16%
EBIT Margin	3.49%
FCF Margin	8.31%

Dividends & Yields

FRA:3H5 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.12%
FCF Yield	2.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:3H5 has an Altman Z-Score of 1 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1
Piotroski F-Score	6